A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christelle Haziza, PhD
Philip Morris Products S.A.
Study Chair - Danielle Armas, MD
Celerion Arizona
Principal Investigator - Darrell Herrington, MD
Benchmark
Principal Investigator - David Subich, MD
Compass Research
Principal Investigator - Derek Schroder, MD
PMG Research of Cary
Principal Investigator - George Raad, MD
PMG Research of Charlotte
Principal Investigator - George Stoica, MD
Compass Research
Principal Investigator - Hugh Coleman, MD
Covance
Principal Investigator - Isabel Kuhare-Arcure, MD
Midwest Clinical Research
Principal Investigator - John Rubino, MD
PMG Research of Raleigh
Principal Investigator - Keith Scott, MD
National Clinical Research
Principal Investigator - Kevin Cannon, MD
PMG Research of Wilmington
Principal Investigator - Laurence Chu, MD
Benchmark
Principal Investigator - Leonard Dunn, MD
Clinical Research West Florida
Principal Investigator - Lon Lynn, MD
Clinical Research West Florida
Principal Investigator - Mark Adams, MD
Central Kentucky Research Associate
Principal Investigator - Peter Davidson, MD
Celerion Lincoln
Principal Investigator - Stephanie Powell, MD
PMG Research of Bristol
Principal Investigator - William Seger, MD
Benchmark
Principal Investigator - William Smith, MD
NOCCR
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Celerion Arizona
Tempe, Arizona, United States
- Clinical Research West Florida
Clearwater, Florida, United States
- Covance, Inc
Daytona Beach, Florida, United States
- Compass Research
Orlando, Florida, United States
- Clinical Research West Florida
Tampa, Florida, United States
- Compass Research
The Villages, Florida, United States
- Central Kentucky Research Associate
Lexington, Kentucky, United States
- Celerion Lincoln
Lincoln, Nebraska, United States
- Pmg Research of Cary
Cary, North Carolina, United States
- Pmg Research of Charlotte
Charlotte, North Carolina, United States
- Pmg Research of Raleigh
Raleigh, North Carolina, United States
- Pmg Research of Wilmington
Wilmington, North Carolina, United States
- Midwest Clinical Research
Dayton, Ohio, United States
- Pmg Research of Bristol
Bristol, Tennessee, United States
- Noccr
Knoxville, Tennessee, United States
- Benchmark
Austin, Texas, United States
- Benchmark
Fort Worth, Texas, United States
- Benchmark
San Angelo, Texas, United States
- National Clinical Research
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2015
- Primary completion
- 13 Mar 2017
- Completion
- 20 Dec 2017
- Last update posted
- 4 Dec 2020
- Registered enrollment
- 672
- Registry id
- NCT02649556
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.